The subcutaneous implantable cardioverter defibrillator––review of the recent data

• Type of Material: Article
• Authors: Stacy Westerman, Emory University; Mikhael F El Chami, Emory University
• Language: English
• Date: 2018-01-01
• Publisher: JGC
• Publication Version: Final Published Version
• Copyright Statement: © 2018 JGC All rights reserved.
• License: Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported
• Final Published Version (URL): http://dx.doi.org/10.11909/j.issn.1671-5411.2018.03.004
• Title of Journal or Parent Work: Journal of geriatric cardiology : JGC
• ISSN: 1671-5411
• Volume: 15
• Issue: 3
• Start Page: 222
• End Page: 228
• Keywords: Inappropriate shocks; Transvenous ICD; Subcutaneous ICD; Sudden Cardiac death
• Research Categories: Health Sciences, General

Abstract

The subcutaneous implantable cardioverter defibrillators (SICD) is an alternative to the transvenous ICD for the prevention of sudden cardiac death (SCD). Multiple studies have shown that the SICD is safe and effective in treating ventricular arrhythmias. While earlier studies mainly enrolled younger patients with channelopathies, more recent reports included patients with “typical” indications for ICD therapy for the prevention of SCD. In this review we summarize the data available to date on the SICD while highlighting its pros and cons.